"Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404," (vol 34, pg 854, 2016)

被引：0
|
作者：
Asselin, Barbara L.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 18期
关键词：
D O I：
10.1200/JCO.2017.73.9433
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2100 / 2100
页数：1
相关论文
共 50 条
  • [31] Apixaban Is Effective and Safe in Reducing Venous Thromboembolism (VTE) in Obese Patients with Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (ALL/LL) a Sub-Study Analysis of the Prevapix-ALL/Children's Oncology Group ACCL1333 Trial
    Rodriguez, Vilmarie
    O'Brien, Sarah
    Lew, Glen
    Orgel, Etan
    Derr, Kimberly
    Ranalli, Mark A.
    Schultz, Corinna L.
    Esbenshade, Adam J.
    Memaj, Arteid
    Dyme, Joshua
    Favatella, Nicholas
    Mitchell, Lesley
    BLOOD, 2023, 142
  • [32] A study of rituximab and ifosfamide, carboplatin, etoposide (ICE) chemotherapy in children with recurrent/refractory B-cell non-Hodgkin lymphoma (NHL) and mature B-cell acute lymphoblastic leukemia (B-ALL). A children's oncology group report
    Griffin, T.
    Weitzman, S.
    Weinstein, H.
    Chang, M.
    Hutchison, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
  • [33] Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group (vol 110, pg 1429, 2007)
    Winter, S. S.
    Jiang, Z.
    Khawaja, H. M.
    Griffin, T.
    Devidas, M.
    Asselin, B. L.
    Larson, R. S.
    BLOOD, 2008, 111 (09) : 4830 - 4830
  • [34] Rituximab therapy for patients with newly diagnosed, asymptomatic advanced-stage follicular grade I non-Hodgkin's lymphoma (NHL): A phase II trial in the North Central Cancer Treatment Group (NCCTG).
    Witzig, TE
    Vukov, AM
    Habermann, TM
    Geyer, S
    Friedenberg, WR
    White, WL
    Salim, M
    Flynn, PJ
    Fitch, TR
    Morton, RF
    BLOOD, 2002, 100 (11) : 361A - 361A
  • [35] Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) for Children and Young Adults with T-Cell Acute Lymphoblastic Leukemia (T-ALL) Treated at Investigator Discretion: A Report from Children's Oncology Group (COG) AALL0434
    Winter, Stuart S.
    Devidas, Meenakshi
    Wood, Brent
    Chen, Zhiguo
    Esiashvili, Natia
    Asselin, Barbara L.
    Loh, Mignon L.
    Rabin, Karen R.
    Raetz, Elizabeth A.
    Zweidler-McKay, Patrick A.
    Schultz, Kirk R.
    Winick, Naomi
    Carroll, William L.
    Hunger, Stephen P.
    Dunsmore, Kimberly P.
    BLOOD, 2018, 132
  • [36] FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children's Cancer Group (vol 112, pg 720, 2020)
    Kumamoto, Tadashi
    Goto, Hiroaki
    Ogawa, Chitose
    Hori, Toshinori
    Deguchi, Takao
    Araki, Takuya
    Saito, Akiko M.
    Manabe, Atsushi
    Horibe, Keizo
    Toyoda, Hidemi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (02) : 308 - 309
  • [37] Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol
    Kikuchi, Akira
    Mori, Tetsuya
    Fujimoto, Jun-Ichiro
    Kumagai, Masaaki
    Sunami, Shosuke
    Okimoto, Yuri
    Tsuchida, Masahiro
    LEUKEMIA & LYMPHOMA, 2008, 49 (04) : 757 - 762
  • [38] PATIENTS WITH EARLY T-CELL PRECURSOR (ETP) ACUTE LYMPHOBLASTIC LEUKEMIA HAVE HIGH LEVELS OF MINIMAL RESIDUAL DISEASE AT THE END OF INDUCTION-A CHILDREN'S ONCOLOGY GROUP (COG) STUDY
    Loh, Mignon
    Winter, Stuart
    Dunsmore, Kimberly
    Raetz, Elizabeth
    Borowitz, Michael
    Devidas, Meenakshi
    Winick, Naomi
    Carroll, William
    Hunger, Stephen
    Wood, Brent
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 788 - 788
  • [39] Risk-Adjusted Therapies Yield Equivalent Outcomes for Adolescents and Young Adults (AYAs) Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) on Children's Oncology Group (COG) Studies AALL0434 and AALL1231
    Colace, Susan I.
    Devidas, Meenakshi
    Chen, Zhiguo
    Hayashi, Robert J.
    Wood, Brent L.
    Esiashvili, Natia
    Patel, Samir
    Carroll, Andrew J.
    Heerema, Nyla A.
    Asselin, Barbara
    Rabin, Karen R.
    Zweidler-McKay, Patrick A.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Winick, Naomi J.
    Carroll, William L.
    Teachey, David T.
    Winter, Stuart S.
    Dunsmore, Kimberly P.
    BLOOD, 2023, 142
  • [40] Risk based and response adapted radiation therapy for children and adolescents with newly diagnosed advanced stage Hodgkin lymphoma treated with ABVD chemotherapy: a report from the Indian pediatric oncology group study InPOG-HL-15-01
    Jain, Sandeep
    Bakhshi, Sameer
    Seth, Rachna
    Verma, Nishant
    Singh, Manisha
    Mahajan, Amita
    Radhakrishnan, Venkatraman
    Mandal, Piali
    Arora, Ramandeep
    Dinand, Veronique
    Kalra, Manas
    Sharma, Anurag
    Taluja, Ankit
    Thulkar, Sanjay
    Biswas, Ahitagni
    Chandra, Jagdish
    LEUKEMIA & LYMPHOMA, 2022, 63 (05) : 1111 - 1118
12345